US Drug Recall Register
Class II · Moderate risk Ongoing Initiated May 21, 2025 (16 months ago)

Tirzepatide Injections

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility

What was recalled

Tirzepatide Injections, 10mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112

Recalling firm
Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)
Origin
CO, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0482-2025

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Tirzepatide recalls

See all
Class II · Moderate risk Ongoing

Tirzepatide Inj

Reason Lack of Assurance of Sterility

New Life Pharma LLC NDC 84223-002-04 D-0395-2026
Class II · Moderate risk Ongoing

Tirzepatide Inj

Reason Lack of Assurance of Sterility

New Life Pharma LLC NDC 84223-002-03 D-0394-2026
Class II · Moderate risk Ongoing

Tirzepatide Injection

Reason Lack of Assurance of Sterility

ProRx LLC D-0120-2026
Class II · Moderate risk Ongoing

Tirzepatide

Reason Lack of Assurance of Sterility

GenoGenix LLC D-0092-2026